Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Comparison of the Revolve™ and AuraGen 1-2-3™ With AuraClens™ Systems in Processing of Lipoaspirate for Autologous Fat Grafting to the Breast

NCT04906811 is registered in ClinicalTrials.gov with AuraGen Aesthetics LLC as lead sponsor.

NCT NCT04906811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04906811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Comparison of the Revolve™ and AuraGen 1-2-3™ With AuraClens™ Systems in Processing of Lipoaspirate for Autologous Fat Grafting to the Breast
Lead sponsor
AuraGen Aesthetics LLC
Phase
Not applicable
Overall status
Terminated
Start date
May 20, 2021
Completion date
February 12, 2024
Enrollment
17 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

autologous fat grafting